IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 219 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,383,027 | -15.5% | 303,962 | +31.0% | 0.00% | 0.0% |
| Q2 2023 | $1,636,439 | +143321.5% | 232,119 | +25.1% | 0.00% | 0.0% |
| Q1 2023 | $1,141 | +110.5% | 185,568 | +118.8% | 0.00% | 0.0% |
| Q4 2022 | $542 | -99.9% | 84,800 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $812,000 | -30.1% | 85,179 | -20.1% | 0.00% | -50.0% |
| Q2 2022 | $1,161,000 | -18.8% | 106,600 | +24.7% | 0.00% | +100.0% |
| Q1 2022 | $1,429,000 | -8.9% | 85,512 | +5.8% | 0.00% | 0.0% |
| Q4 2021 | $1,569,000 | -33.1% | 80,788 | -18.0% | 0.00% | -66.7% |
| Q3 2021 | $2,345,000 | -42.0% | 98,559 | -35.8% | 0.00% | -50.0% |
| Q2 2021 | $4,043,000 | – | 153,549 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,876,600 | $127,618,000 | 11.48% |
| Fairmount Funds Management LLC | 596,890 | $19,650,000 | 8.32% |
| Ghost Tree Capital, LLC | 575,000 | $18,929,000 | 5.47% |
| Perceptive Advisors | 10,085,632 | $332,019,000 | 4.85% |
| Avoro Capital Advisors LLC | 9,536,039 | $313,926,000 | 4.46% |
| FRAZIER MANAGEMENT LLC | 1,312,999 | $43,224,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 315,000 | $10,370,000 | 2.82% |
| Orbimed Advisors | 6,645,100 | $218,757,000 | 2.75% |
| QVT Financial LP | 572,971 | $18,862,000 | 2.30% |
| Prosight Management, LP | 120,606 | $3,970,000 | 1.89% |